Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tybost vs Norvir as Boosters for Reyataz in HIV-1
NCT01108510Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of cobicistat in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Apr 2010; status: completed.
02
Drugs
cobicistat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01108510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108510.